"I don't think that it's a
green light for all PBM regulations, but certainly anything that's a cost
regulation. And that's what they concluded, that they didn't really care that
[Act 900] had disuniformity issues — they saw it as a cost regulation."
— Washington, D.C.-based lawyer David Ermer, whose practice
focuses on the Federal Employees Health Benefits Program, spoke with AIS's RADAR on Drug Benefits about
the U.S. Supreme Court's recent decision in Rutledge
v. PCMA, which will allow states to continue to tighten regulations
on PBMs.
Subscribers may read the RADAR on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment